FDA issues infusion pump recall over stalled motors.

MedPage Today (12/27, Petrochko) reports that the FDA “has issued a class I recall of two infusion pumps citing motor failure when used with drugs not specifically approved for them.” The two models of pumps are the “SynchroMed II Implantable and SynchroMed EL Implantable infusion pumps,” which “may stall intermittently or permanently,” and can “lead to serious adverse events and death.” The pumps are approved for use with “morphine (Infumorph), baclofen (Lioresal and Gablofen ), ziconotide (Prialt), floxuridine, and methotrexate.”